Stocks / Stock overview

ASP Isotopes Inc. (ASPI)

$3.88-3.96%Aft $3.92 (+1.04%)Market cap $594.8M

NasdaqCM · Price as of · Nasdaq Real Time Price

Stock Scorer
F28/100
  • Profitability5/20

    Losing money ($-117.3M over the last four reported quarters), but the top line is growing fast. Revenue over the last four reported quarters was $30.9M, up 558% from $4.7M the year before. Growth this quick earns partial credit; it still has to turn into profit.

  • Insider buying vs selling8/20

    Insiders are sellers only: 15 sells worth $5.0M, no open-market buys, across the last 15 Form 4s. Routine executive selling is common, so this is only a mild negative.

  • Dilution and offerings1/15

    Share count up 66.8% in a year and 4 offering-related filings. Heavy dilution. One nuance: offerings raise cash that can fund real growth. The score docks the certain near-term dilution; if the spending pays off, it shows up later in the profitability component.

See the full breakdown
Analyst consensus
Strong buy$13.00
  • Analysts3
  • Implied upside+235.1%
  • Target range$11.00 to $15.00
Analyst estimates are opinions, not forecasts of what the stock will do.
Source: Yahoo Finance consensus, retrieved
Next earnings
November 12, 2026date estimated
  • EPS expected-$0.13
  • A year ago-$0.15
  • Revenue expected$4.8M -1.2%
Consensus of 1 analyst for the quarter ending September 30, 2026. Estimates are what Wall Street expects, not our forecast.
Source: Yahoo Finance earnings calendar
ASPI past month-2.5%
ASPI closed at $3.88 on Aug 28, down 2.5% since Jul 30.$3.88$6.28Jul 30Aug 28
Close 20-day average 50-day average 200-day average

ASPI closed at $3.88 on Aug 28, down 2.5% since Jul 30. Chart read: price below both the 50-day and 200-day moving averages; the 50-day is below the 200-day (downtrend structure); trading at 3% of the 52-week range ($3.54 to $14.05).

Insider buying and selling at ASP Isotopes Inc. (ASPI)

Source: SEC Form 4 filingsLatest filed

The most recent Form 4 on record for ASP Isotopes Inc. (ASPI) is June 3, 2026, when Paul Elliot Mann, Chairman and CEO, sold $2.0M of stock. Those shares went automatically to cover tax on a vest, so it was not a decision to sell.

InsiderActionValueDateType
Paul Elliot Mann · Chairman and CEOSell$2.0MJune 3, 2026Tax withholding
Paul Elliot Mann · Executive ChairmanSell$881,464March 2, 2026Tax withholding
Paul Elliot Mann · Executive ChairmanSell$932,866December 3, 2025Tax withholding
Paul Elliot Mann · Executive OfficerSell$1.1MNovember 28, 2025Routine
Paul Elliot Mann · Chief Executive OfficerSell$1.4MSeptember 10, 2025Tax withholding
All insider activity

SEC filings

Source: SEC EDGARLatest filed

FormFiledDescription
425August 21, 2026FORM 425
8-KAugust 20, 2026FORM 8-K
425August 20, 2026425
8-KAugust 20, 20268-K
8-KAugust 18, 20268-K
10-QAugust 14, 202610-Q
425August 6, 2026425
8-KAugust 6, 20268-K
All SEC filings

Frequently asked questions

When does ASPI report earnings?

ASP Isotopes Inc. (ASPI) is scheduled to report quarterly results on November 12, 2026 (estimated). The 1-analyst consensus is -$0.13 per share on revenue of $4.8M for the quarter ending September 30, 2026, against -$0.15 and $4.9M a year earlier. The date is an estimate from past reporting patterns and can move until the company confirms it.

What do analysts expect for ASPI?

3 analysts cover ASP Isotopes Inc. (ASPI). The consensus rating is Strong buy. The average price target is $13.00, in a range of $11.00 to $15.00.

Are insiders buying or selling ASPI?

We track Form 4 filings for ASP Isotopes Inc. (ASPI). The activity listed on this page shows 5 qualifying sales. Each row is labelled Routine when the filer declared a pre-arranged 10b5-1 plan, Tax withholding when shares were sold automatically to cover the tax on a vest, or Own call when neither applies.

Where can I see ASPI SEC filings?

Recent filings are listed on this page, newest first. The latest is a 425 filed August 21, 2026.

Data on this page comes from SEC EDGAR, public disclosure feeds and market data providers, and may be delayed or incomplete. Nothing here is investment advice.